Funding for this research was provided by:
Instituto de Salud Carlos III (RD12/0036/0003, PI19/00808)
Ministerio de Economía, Industria y Competitividad, Gobierno de España (BFU2015-71371-R)
Fundación Científica Asociación Española Contra el Cáncer
Diputación de Albacete
CIBERONC and CRIS CANCER FUNDATION
Received: 9 July 2020
Accepted: 10 August 2020
First Online: 15 September 2020
Ethics approval and consent to participate
: Not applicable.
: Not Applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.